Active

Evonik invites startups to join the Catalysis Strategy Symposium:Transforming Tomorrow in Life Sciences

Deadline: April 27, 2026

Evonik is hosting Transforming Tomorrow: Catalysis in Life Sciences on April 28, a symposium exploring how catalytic strategies and technologies are shaping the next generation of life science innovation. The event will highlight advances in catalytic processes, materials, and products that are enabling more efficient, scalable, and sustainable approaches to pharmaceutical and biotechnology development. Attendance is free.

Startups can register here to attend the symposium.

The event welcomes startups, founders, and aspiring entrepreneurs for an opportunity to engage with leading scientists and industry experts working at the forefront of catalysis and life sciences. Discussions will span topics such as sustainable pharmaceutical manufacturing, reaction optimization, and emerging continuous flow technologies. The symposium is designed to provide practical technical insights while creating opportunities for dialogue between innovators, researchers, and industry leaders.

Key learnings for participants

  • Designing efficient and sustainable pharmaceutical processes
  • Designing batch and continuous processes
  • Advances in heterogeneous catalysis

 

Agenda
 

08:30 am | Registration & Light refreshments

Eric Neuffer

Drug Substance Business Head – New Business Development

Evonik Health Care

 

09:00 am | Welcome & Introduction

Gustavo Castro

Sr. Business Manager for North America

Evonik Catalysts

 

Anil Saxena

Head of Americas RD&I Open Innovation

Evonik Americas, Research, Development & Innovation

 

09:10 am | Heterogeneous Catalysis in Flow Chemistry & Nickel Foam

ShaRee Thomas

Applied Technology Manager

Evonik Catalysts

 

09:50 am | Hybrid-AI Digital Twins for Modeling & Scaling a Batch to Continuous Catalytic Hydrogenation

Trevor Murray

Strategic Account Executive – Life Sciences

Basetwo AI

 

10:30 am | Break

 

10:45 am | Overcoming the Selectivity Issue in a Nickel Catalyzed Batch Hydrogenation

Michael Nonnenmacher

Director Global Business Development Differentiating Technologies for Drug Substance

Evonik Health Care

 

11:30 am | Using Interfacial Charge Separation to Understand and Control Catalysis

Prof. Yogesh Surendranath

Donner Professor of Science; Professor of Chemistry, Chemical Engineering

Massachusetts Institute of Technology

 

12:15 pm | Lunch & Networking

 

01:15 pm | Heterogeneous Catalysis in CC Coupling

Maxim Radzhabov

Project Leader

Evonik Catalysts

 

01:55 pm | Selective Oxygenate Chemistry with Solid Acid Catalysts

Prof. Friederike Jentoft

Professor, Chemical and Biomolecular Engineering

University of Massachusetts Amherst

 

02:40 pm | Guest Speaker

Andrea Adamo, Founder & CEO

Lorenzo Milani, Senior Chemical Engineer

Zaiput Flow Technologies

03:20 pm | Evonik Lab Tour

03:50 pm | Conclusion of Event

Deadline: April 27, 2026
Posted on: March 6, 2026
Location: Cambridge, MA
Industry: pharmaceuticals, biotech, manufacturing, packaging, circular economy, heathcare

Evonik is hosting Transforming Tomorrow: Catalysis in Life Sciences on April 28, a symposium exploring how catalytic strategies and technologies are shaping the next generation of life science innovation. The event will highlight advances in catalytic processes, materials, and products that are enabling more efficient, scalable, and sustainable approaches to pharmaceutical and biotechnology development. Attendance is free.

Startups can register here to attend the symposium.

The event welcomes startups, founders, and aspiring entrepreneurs for an opportunity to engage with leading scientists and industry experts working at the forefront of catalysis and life sciences. Discussions will span topics such as sustainable pharmaceutical manufacturing, reaction optimization, and emerging continuous flow technologies. The symposium is designed to provide practical technical insights while creating opportunities for dialogue between innovators, researchers, and industry leaders.

Key learnings for participants

  • Designing efficient and sustainable pharmaceutical processes
  • Designing batch and continuous processes
  • Advances in heterogeneous catalysis

 

Agenda
 

08:30 am | Registration & Light refreshments

Eric Neuffer

Drug Substance Business Head – New Business Development

Evonik Health Care

 

09:00 am | Welcome & Introduction

Gustavo Castro

Sr. Business Manager for North America

Evonik Catalysts

 

Anil Saxena

Head of Americas RD&I Open Innovation

Evonik Americas, Research, Development & Innovation

 

09:10 am | Heterogeneous Catalysis in Flow Chemistry & Nickel Foam

ShaRee Thomas

Applied Technology Manager

Evonik Catalysts

 

09:50 am | Hybrid-AI Digital Twins for Modeling & Scaling a Batch to Continuous Catalytic Hydrogenation

Trevor Murray

Strategic Account Executive – Life Sciences

Basetwo AI

 

10:30 am | Break

 

10:45 am | Overcoming the Selectivity Issue in a Nickel Catalyzed Batch Hydrogenation

Michael Nonnenmacher

Director Global Business Development Differentiating Technologies for Drug Substance

Evonik Health Care

 

11:30 am | Using Interfacial Charge Separation to Understand and Control Catalysis

Prof. Yogesh Surendranath

Donner Professor of Science; Professor of Chemistry, Chemical Engineering

Massachusetts Institute of Technology

 

12:15 pm | Lunch & Networking

 

01:15 pm | Heterogeneous Catalysis in CC Coupling

Maxim Radzhabov

Project Leader

Evonik Catalysts

 

01:55 pm | Selective Oxygenate Chemistry with Solid Acid Catalysts

Prof. Friederike Jentoft

Professor, Chemical and Biomolecular Engineering

University of Massachusetts Amherst

 

02:40 pm | Guest Speaker

Andrea Adamo, Founder & CEO

Lorenzo Milani, Senior Chemical Engineer

Zaiput Flow Technologies

03:20 pm | Evonik Lab Tour

03:50 pm | Conclusion of Event

About Evonik

Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise.

The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €14.1 billion and earnings (adjusted EBITDA) of €1.9 billion in 2025. The common motivation of the approximately 31,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. 

  • About Evonik

    Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise.

    The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €14.1 billion and earnings (adjusted EBITDA) of €1.9 billion in 2025. The common motivation of the approximately 31,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. 


Disclaimer:  MIT Startup Exchange can make introductions that ideally provide open ended discussions in order to share mutual interests and potentially create common ground that incite the parties to collaborate. MIT Startup Exchange introductions may eventually lead to mutual partnerships, but that is not in any way guaranteed by MIT, MIT Corporate Relations, MIT Industrial Liaison Program (ILP) or MIT Startup Exchange, which takes no responsibility for these outcomes and no formal part in such discussions following our introduction. MIT Startup Exchange and its activities and events are not for purposes of soliciting investment or offering securities.